The purpose of this study is to evaluate the impact of providing newly diagnosed prostate cancer patients and their caregivers with an interactive mobile tablet technology-based application delivered by a community navigator versus providing National Cancer Institute (NCI) information booklets delivered by a Community Navigator (CN) on patient outcomes (decisional satisfaction, quality of life, knowledge, decisional conflict) and shared decision making practices (decision making involvement).

Inclusion Criteria:

• Men newly diagnosed (within 6 months) with biopsy confirmed case of prostate cancer
• 40 - 80 years of age
• Able to speak and read English
• Live within 120 miles of a healthcare treatment facility
• Have no documented or observable visual, auditory, psychiatric, or neurological disorders that would interfere with study participation
• Be able to complete telephone interviews
• Have not completed the first course of treatment
• Have a family member/caregiver willing to participate
• Capable of providing written consent for study participation. Men diagnosed with early stage, locally advanced or metastatic disease or men who are on active surveillance will be eligible to participate in this study.
• Caregiver must be aged 18 or older
• Caregiver must be identified by patient as their caregiver (i.e., provider of emotional and/or physical care)
• Caregiver must have not been diagnosed with cancer in the previous year or be receiving cancer treatment

Patients from Moffitt Cancer Center Genitourinary Clinic, University of South Florida Genitourinary Clinic, or community-based urologists and primary care providers.